Diseases of the Esophagus · 2010 · 37 citations · 27 references
MedicineOncologyPharmacologyChemotherapyGastrointestinal OncologyMetastasisCombination ChemotherapyEsophageal CancerMalignant NeoplasmsMetastatic Disease TreatmentSquamous Cell CarcinomaToxicity Management5-Fluorouracil TherapyAnthracycline-based ChemotherapyComplete Response AssessmentDoxorubicin-based TherapyEsophageal Cancer PharmacotherapyMetastatic Esophageal Cancer
The chemotherapy regimen currently used for treating esophageal and gastric carcinoma has been either epirubicin, cisplatin, and fluorouracil (5-FU) or docetaxel, cisplatin, and 5-FU. Here, we report the efficacy and toxicity of doxorubicin, cisplatin, and 5-FU for only esophageal squamous cell carcinoma (ESCC). Between January 2000 and October 2008, a total of 41 ESCC patients with a distant metastasis were enrolled. The most common sites of metastasis were liver (26, 63.4%), lung (9, 22.0%), and bone (8, 19.5%). Doxorubicin was administered on day 1 at 30 mg/m(2) , cisplatin on days 1-5 at 14 mg/m(2)/day, and 5-FU on days 1-5 at 700 mg/m(2)/day. The median number of cycles was 2.0 (range 1-8). The dose intensities of doxorubicin, cisplatin, and 5-FU were 92.9, 92.4, and 92.5%, respectively. The overall response rate was 43.9%; one showed complete response, 17 showed partial response, 13 showed a stable disease, and 10 showed progressive disease (PD). The median survival time was 306 days (95% CI = 74-935) and the 1-year survival rate was 37.6%. Grade 3 neutropenia was seen in seven patients and grade 4 in one patient. Grade 3 fatigue, anorexia, mucositis, and diarrhea were observed in three, two, two, and one patient, respectively. This regimen is effective as a first-line therapy for ESCC with distant metastasis.
27
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
David Cunningham, Naureen Starling, Sheela Rao et al. · New England Journal of Medicine · 2008 · 2.3K citations
Medicine, Oncology, Pharmacology +12
Eric Van Cutsem, Vladimir Moiseyenko, Sergei Tjulandin et al. · Journal of Clinical Oncology · 2006 · 1.9K citations · Full text
Medicine, Oncology, Pharmacology +11
Paul J. Ross, M. Nicolson, David Cunningham et al. · Journal of Clinical Oncology · 2002 · 482 citations
Medicine, Oncology, Pharmacology +11